Successful pregnancy outcome in a woman with malignant bilateral ovarian germ cell tumor

Authors

  • Rohan Sodhi Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, India
  • Aashima Arora Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, India
  • Pariksha Gupta Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, India
  • Bhavana Rai Department of Radiotherapy, PGIMER, Chandigarh, India
  • G. R. V. Prasad Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, India
  • Nidhi Prabhakar Department of Radiodiagnosis and Imaging, PGIMER, Chandigarh, India
  • Plaksha Goel Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20250891

Keywords:

Ovarian tumor, Germ cell tumor, Pregnancy post-chemotherapy

Abstract

Malignant ovarian germ cell tumors (MOGCT) are rare, accounting for 5% of all ovarian malignancies. In the first two decades of life, almost 70% of ovarian tumors are germ cell tumors and of these one-third are malignant. Bilateral involvement in MOGCT is very rare. This case presented a unique challenge of fertility-sparing surgery in the case of MOGCT. Although fertility-sparing surgery is recommended even in advanced stages if fertility is desired, the bilaterality of disease precluded the option in the index case. Neoadjuvant chemotherapy has been attempted in patients with malignant ovarian germ cell tumors with extensive intra-abdominal disease. Current chemotherapy for GCT has more than 80% chances of menstruation, more than 70% pregnancy rates with no increase in risk of teratogenicity, and less than 10% risk of premature ovarian failure. In our case not only the patient had a successful debulking surgery post NACT without any signs of recurrence, but also had a spontaneous conception with a successful pregnancy outcome with no complications pertaining to prior treatment given.

Metrics

Metrics Loading ...

References

JungKW,Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Prediction of cancer incidence and mortality in Korea, 2014. Cancer Res Treat. 2014;46:124–30. DOI: https://doi.org/10.4143/crt.2014.46.2.124

Kurman RJ, Norris HJ: Malignant germ cell tumors of the ovary. Hum Pathol 8;551:564, DOI: https://doi.org/10.1016/S0046-8177(77)80115-9

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ovarian cancer including fallopian tube cancer and primary peritoneal cancer Version 2.2019 NCCN Guidelines for Patients; National Comprehensive Cancer Network: Washington, DC, USA. 2019.

Talukdar S, Kumar S, Bhatla N, Mathur S, Thulkar S, Kumar L. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol. 2014;132(1):28-32. DOI: https://doi.org/10.1016/j.ygyno.2013.10.009

Raveendran A, Gupta S, Bagga R, Saha SC, Gainder S, Dhaliwal LK, et al. Advanced germ cell malignancies of the ovary: should neo-adjuvant chemotherapy be the first line of treatment. J Obstet Gynaecol. 2010;30(1):53-5. DOI: https://doi.org/10.3109/01443610903383366

Vasta FM, Dellino M, Bergamini A, Gargano G, Paradiso A, Loizzi V, et al. Reproductive outcomes and fertility preservation strategies in women with malignant ovarian germ cell tumors after fertility sparing surgery. Biomedicines. 2020;8(12):554. DOI: https://doi.org/10.3390/biomedicines8120554

Downloads

Published

2025-03-27

How to Cite

Sodhi, R., Arora, A., Gupta, P., Rai, B., Prasad, G. R. V., Prabhakar, N., & Goel, P. (2025). Successful pregnancy outcome in a woman with malignant bilateral ovarian germ cell tumor. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(4), 1360–1363. https://doi.org/10.18203/2320-1770.ijrcog20250891

Issue

Section

Case Reports